World AMR Congress 2021: Biotechs are saving the world from superbugs. Can they also save themselves?

About the session
During her presentation, Fatema will discuss the Access to Medicine Foundation's latest research, which investigates the small drugmakers that drive antibiotic and antifungal R&D and their chances of surviving tough financial conditions to bring new medicines to market. She will also discuss the 2021 Antimicrobial Resistance Benchmark which will be published in the following weeks.

About the event
Antimicrobial resistance (AMR) is one of the biggest global health crises facing the world today. The number of deaths attributed to AMR is expected to surpass the number of deaths from cancer worldwide by 2050.

Since 2015, the World Anti-Microbial Resistance Congress has been the go-to conference globally for all stakeholders in the AMR space to meet, brainstorm ideas and formulate initiatives that can effectively tackle this pressing issue.

Industry leaders, innovative technology and solution providers, public authorities, international organizations, infectious disease clinicians, pharmacists and microbiologists are some of the 500+ attendees will gather this November 2021 at the World Anti-Microbial Resistance Congress in Washington, DC.

Please click here for more information.